--:--:--ET

live

S&P 5007,512.99-0.55%

NASDAQ29,968.13-1.89%

DOW51,999.67+0.64%

VIX16.41+1.30%

US10Y4.43-0.92%

EUR/USD1.1615+0.20%

GOLD4,355.5+0.47%

WTI75.90-6.78%

BTC65,667.9-0.74%

S&P 5007,512.99-0.55%

NASDAQ29,968.13-1.89%

DOW51,999.67+0.64%

VIX16.41+1.30%

US10Y4.43-0.92%

EUR/USD1.1615+0.20%

GOLD4,355.5+0.47%

WTI75.90-6.78%

BTC65,667.9-0.74%

VRTX

Vertex Pharmaceuticals Incorporated

HealthcareBiotechnologyUSUSDPeers →

$450.46

LiveJun 15, 2026

Market cap

$114.33B

52w range

362.50 – 507.92

P / E

—

EPS · FY 2025

$15.32

Volume

1.48M

Revenue · FY 2025

$12.07B

+9.57% YoY

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Financials Enterprise value Ratios Multiples Segments Profile Management

Explain this page

Arphra AIPlain-English read on Vertex Pharmaceuticals Incorporated’s valuation

Pro

Segment breakdown

Revenue and profit by segment is included with Pro.